These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 22334268)

  • 1. Basic science for the clinician 54: CD5.
    Sigal LH
    J Clin Rheumatol; 2012 Mar; 18(2):83-8. PubMed ID: 22334268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD5: a safeguard against autoimmunity and a shield for cancer cells.
    Dalloul A
    Autoimmun Rev; 2009 Feb; 8(4):349-53. PubMed ID: 19041428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. B-cell linker protein expression contributes to controlling allergic and autoimmune diseases by mediating IL-10 production in regulatory B cells.
    Jin G; Hamaguchi Y; Matsushita T; Hasegawa M; Le Huu D; Ishiura N; Naka K; Hirao A; Takehara K; Fujimoto M
    J Allergy Clin Immunol; 2013 Jun; 131(6):1674-82. PubMed ID: 23534976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD5-positive B cells at the crossroads of B cell malignancy and nonorgan-specific autoimmunity.
    Youinou P; Pers JO; Jamin C; Lydyard PM
    Pathol Biol (Paris); 2000 Jul; 48(6):574-6. PubMed ID: 10965537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The paradox of CD5-expressing B cells in systemic lupus erythematosus.
    Youinou P; Renaudineau Y
    Autoimmun Rev; 2007 Dec; 7(2):149-54. PubMed ID: 18035326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased numbers of CD5+ B lymphocytes with a regulatory phenotype in spondylarthritis.
    Cantaert T; Doorenspleet ME; Francosalinas G; Paramarta JE; Klarenbeek PL; Tiersma Y; van der Loos CM; De Vries N; Tak PP; Baeten DL
    Arthritis Rheum; 2012 Jun; 64(6):1859-68. PubMed ID: 22231660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. B lymphocytes on the front line of autoimmunity.
    Youinou P; Hillion S; Jamin C; Pers JO; Saraux A; Renaudineau Y
    Autoimmun Rev; 2006 Mar; 5(3):215-21. PubMed ID: 16483922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The antiphospholipid syndrome as a model for B cell-induced autoimmune diseases.
    Youinou P; Renaudineau Y
    Thromb Res; 2004; 114(5-6):363-9. PubMed ID: 15507266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B lymphocytes are required for development and treatment of autoimmune diseases.
    Youinou P; Jamin C; Pers JO; Berthou C; Saraux A; Renaudineau Y
    Ann N Y Acad Sci; 2005 Jun; 1050():19-33. PubMed ID: 16014517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue-specific expansion of NKT and CD5+B cells at the onset of autoimmune disease in (NZBxNZW)F1 mice.
    Morshed SR; Mannoor K; Halder RC; Kawamura H; Bannai M; Sekikawa H; Watanabe H; Abo T
    Eur J Immunol; 2002 Sep; 32(9):2551-61. PubMed ID: 12207339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulatory T cells as central regulators of both autoimmunity and B cell malignancy in New Zealand Black mice.
    Scaglione BJ; Salerno E; Gala K; Pan M; Langer JA; Mostowski HS; Bauer S; Marti G; Li Y; Tsiagbe VK; Raveche ES
    J Autoimmun; 2009 Feb; 32(1):14-23. PubMed ID: 19022624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravascular large B-cell lymphoma: the CD5 antigen is expressed by a subset of cases.
    Khalidi HS; Brynes RK; Browne P; Koo CH; Battifora H; Medeiros LJ
    Mod Pathol; 1998 Oct; 11(10):983-8. PubMed ID: 9796727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulatory B cells in autoimmune diseases: how do they work?
    Lemoine S; Morva A; Youinou P; Jamin C
    Ann N Y Acad Sci; 2009 Sep; 1173():260-7. PubMed ID: 19758160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estrogen induces normal murine CD5+ B cells to produce autoantibodies.
    Ansar Ahmed S; Dauphinée MJ; Montoya AI; Talal N
    J Immunol; 1989 Apr; 142(8):2647-53. PubMed ID: 2467934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD5- dendritic epidermal T cells are derived from CD5+ precursor cells.
    Payer E; Kutil R; Stingl G
    Eur J Immunol; 1994 Jun; 24(6):1317-22. PubMed ID: 7515810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD5+ B lymphocytes, polyreactive antibodies and the human B-cell repertoire.
    Casali P; Notkins AL
    Immunol Today; 1989 Nov; 10(11):364-8. PubMed ID: 2482031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and regulation of CD5 on in vitro activated human B cells.
    Freedman AS; Freeman G; Whitman J; Segil J; Daley J; Levine H; Nadler LM
    Eur J Immunol; 1989 May; 19(5):849-55. PubMed ID: 2472277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [B cells as key contributors in determining the level of immune responses -B-cell-targeted therapy in patients with autoimmune diseases].
    Kondo S; Akashi T; Katsuta H; Iwakiri R; Anzai K; Nagafuchi S; Niho Y; Harada M
    Fukuoka Igaku Zasshi; 2005 Apr; 96(4):86-92. PubMed ID: 15991605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of B-1a cells in autoimmunity.
    Duan B; Morel L
    Autoimmun Rev; 2006 Jul; 5(6):403-8. PubMed ID: 16890894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of B lymphocytes in the progression from autoimmunity to autoimmune disease.
    Salinas GF; Braza F; Brouard S; Tak PP; Baeten D
    Clin Immunol; 2013 Jan; 146(1):34-45. PubMed ID: 23202542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.